Loading clinical trials...
Loading clinical trials...
A Dose Ranging Study of the Safety and Efficacy of LIPO-202 Healthy Patients With Subcutaneous Fat in the Periumbilical Area
Dose Ranging Study
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
United States, California
Beverly Hills, California, United States
United States, California
Encinitas, California, United States
United States, California
Los Angeles, California, United States
United States, California
San Diego, California, United States
United States, California
Santa Ana, California, United States
United States, Florida
Aventura, Florida, United States
United States, Florida
Clearwater, Florida, United States
United States, Florida
Lake Worth, Florida, United States
United States, Florida
Miami, Florida, United States
United States, Florida
Tampa, Florida, United States
Start Date
February 1, 2013
Primary Completion Date
June 1, 2013
Completion Date
October 1, 2013
Last Updated
March 26, 2015
472
ACTUAL participants
Drug: salmeterol xinafoate
DRUG
Drug: Placebo
DRUG
Lead Sponsor
Neothetics, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions